|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Memory Clinic, Geriatric Division and Department of Metabolic Diseases, Ospedale Regionale della Beata Vergine, Mendrisio, Switzerland (PQ, CF, RP, and EZ); Laboratory of Geriatric Neuropsychiatry and Laboratory of Biology of Neurodegenerative Disorders, Department of Neuroscience, Istituto di Ricerche Farmacologiche "Mario Negri", Milano, Italy (GF, MT, and UL).
Background: Evidence supports an independent association between plasma total homocysteine concentrations and the risk of vascular disease. Recent epidemiologic studies reappraised the possibility that vascular risk factors might play a role in the pathogenesis not only of vascular dementia (VaD) but also of Alzheimer disease (AD).
Objective: The objective was to investigate the relations of mild cognitive impairment, AD, and VaD with blood homocysteine, folate, and vitamin B-12.
Design: The study population consisted of 314 consecutive subjects, 228 of whom were eligible for analyses. Plasma total homocysteine, serum folate, and serum vitamin B-12 concentrations were measured in 55 nondemented elderly control subjects, 81 mildly cognitively impaired subjects (Clinical Dementia Rating: 0.5), and 92 demented patients prevalently in a mild disease stage and with a clinical diagnosis of AD (n = 74) or VaD (n = 18).
Results: Subjects in the lowest folate tertile had significantly higher adjusted odds ratios (ORs) for mild cognitive impairment (OR: 3.1; 95% CI: 1.2, 8.1) and dementia (3.8; 1.3, 11.2). Hyperhomocysteinemia was significantly associated with dementia (adjusted OR: 4.3; 1.3, 14.7) and AD (adjusted OR: 3.7; 1.1, 13.1). In subjects with a Clinical Dementia Rating of 0.5, the mean (± SE) Mini-Mental State Examination score was significantly lower (P < 0.05) in the highest homocysteine tertile (24.5 ± 0.5) than in the lowest tertile (26.6 ± 0.5). No significant associations were found between minimum medial temporal lobe thickness or leukoaraiosis and any biochemical measure in the dementia and AD groups.
Conclusions: These findings suggest that relative folate deficiency may precede AD and VaD onset. Hyperhomocysteinemia might also be an early risk factor for cognitive decline in the elderly, but its role in dementia development must be addressed in future longitudinal studies.
Key Words: Folate vitamin B-12 homocysteine mild cognitive impairment Alzheimer disease vascular dementia
This article has been cited by other articles:
![]() |
L. Feng, J. Li, K.-B. Yap, E.-H. Kua, and T.-P. Ng Vitamin B-12, apolipoprotein E genotype, and cognitive performance in community-living older adults: evidence of a gene-micronutrient interaction Am. J. Clinical Nutrition, April 1, 2009; 89(4): 1263 - 1268. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Rabaneda, M. Carrasco, M. A. Lopez-Toledano, M. Murillo-Carretero, F. A. Ruiz, C. Estrada, and C. Castro Homocysteine inhibits proliferation of neuronal precursors in the mouse adult brain by impairing the basic fibroblast growth factor signaling cascade and reducing extracellular regulated kinase 1/2-dependent cyclin E expression FASEB J, November 1, 2008; 22(11): 3823 - 3835. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Merete, L. M. Falcon, and K. L. Tucker Vitamin B6 Is Associated with Depressive Symptomatology in Massachusetts Elders J. Am. Coll. Nutr., June 1, 2008; 27(3): 421 - 427. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. de Lau, H. Refsum, A D. Smith, C. Johnston, and M. M. Breteler Plasma folate concentration and cognitive performance: Rotterdam Scan Study Am. J. Clinical Nutrition, September 1, 2007; 86(3): 728 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kim, M. H. Park, E. Kim, C. Han, S. A. Jo, and I. Jo Plasma Homocysteine Is Associated with the Risk of Mild Cognitive Impairment in an Elderly Korean Population J. Nutr., September 1, 2007; 137(9): 2093 - 2097. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Raman, A. Tatsioni, M. Chung, I. H. Rosenberg, J. Lau, A. H. Lichtenstein, and E. M. Balk Heterogeneity and Lack of Good Quality Studies Limit Association Between Folate, Vitamins B-6 and B-12, and Cognitive Function J. Nutr., July 1, 2007; 137(7): 1789 - 1794. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-K. Yang, K.-C. Wong, M.-Y. Wu, S.-L. Liao, C.-S. Kuo, and R.-F. S. Huang Correlations Between Folate, B12, Homocysteine Levels, and Radiological Markers of Neuropathology in Elderly Post-Stroke Patients J. Am. Coll. Nutr., June 1, 2007; 26(3): 272 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hao, J. Ma, J. Zhu, M. J. Stampfer, Y. Tian, W. C. Willett, and Z. Li High Prevalence of Hyperhomocysteinemia in Chinese Adults Is Associated with Low Folate, Vitamin B-12, and Vitamin B-6 Status J. Nutr., February 1, 2007; 137(2): 407 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Feng, T.-P. Ng, L. Chuah, M. Niti, and E.-H. Kua Homocysteine, folate, and vitamin B-12 and cognitive performance in older Chinese adults: findings from the Singapore Longitudinal Ageing Study Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1506 - 1512. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tettamanti, M. T. Garri, A. Nobili, E. Riva, and U. Lucca Low Folate and the Risk of Cognitive and Functional Deficits in the Very Old: The Monzino 80-plus Study J. Am. Coll. Nutr., December 1, 2006; 25(6): 502 - 508. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I Ramos, L. H Allen, D. M Mungas, W. J Jagust, M. N Haan, R. Green, and J. W Miller Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1346 - 1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ravaglia, P. Forti, F. Maioli, M. Martelli, L. Servadei, N. Brunetti, E. Porcellini, and F. Licastro Homocysteine and folate as risk factors for dementia and Alzheimer disease Am. J. Clinical Nutrition, September 1, 2005; 82(3): 636 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A Bartley, B. A Underwood, and R. J Deckelbaum A life cycle micronutrient perspective for women's health Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1188S - 1193S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gauthier The benefits of apolipoprotein E {epsilon}4 screening to research Can. Med. Assoc. J., October 12, 2004; 171(8): 881 - 881. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |